RBC Capital analyst Arun Viswanathan maintained a Hold rating on Pactiv Evergreen (PTVE – Research Report) yesterday and set a price target of ...

In a report released yesterday, Tom Narayan from RBC Capital maintained a Hold rating on Mobileye Global, Inc. Class A (MBLY – Research ...

Brian McGill and Michael Hyser operate as Johns Creek Financial along with support-staff members Stacie Alexander and Alexis ...

Street Talk understands Hong Kong’s Chow Tai Fook has tapped investment banks UBS and RBC Capital Markets for advice. How much Alinta’s owners are looking to part with is unclear, but Chow Tai ...

BMO Capital Markets has recently reduced Exelixis Inc (EXEL) stock to Market Perform rating, as announced on December 20, 2024, according to Finviz. Earlier, on December 17, 2024, BofA Securities had ...

UBS updated its outlook for U.S. midcap banks, revising earnings estimates and highlighting key performers in the sector. Analysts noted that since the start of bank earnings announcements last week, ...

On Friday, Exelixis Inc (EXEL) stock saw a decline, ending the day at $32.38 which represents a decrease of $-1.75 or -5.13% from the prior close of $34.13. The stock opened at $33.49 and touched a ...

Wells Fargo CEO Charlie Scharf validates some of the optimism, telling analysts he feels "really great about our progress." ...

Ninety One, the £130bn UK fixed income and equities asset manager, has hired Justin Jewell as portfolio manager for its ...

Birds of a feather Several Wall Street analysts have similar ideas about how the S&P 500 will fare this year. The consensus ...

UBS initiated coverage on Penumbra (NYSE:PEN), a medical technology company, with a Buy rating and a price target of $305.00. Trading at $263.69 and with a market capitalization of $10.12 billion, the ...

On Thursday, RBC Capital Markets adjusted its outlook on shares ... driven by expected higher revenues and share buybacks. UBS increased their price target for JPMorgan shares to $287 from the ...